Pharmaceutical Research · 2012 · 15 citations · 20 references
The results indicate that SMEDDS is a promising novel formulation to enhance the oral bioavailability of paclitaxel, especially when coadministered with a suitable P-gp inhibitor, such as CsA.
20
Olena Medelyan, David Milne, Catherine Legg et al. · International Journal of Human-Computer Studies · 2009 · 357 citations · Full text